1-9 of 9
Amanda Johnston
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pegargiminase (ADI-PEG 20), Venetoclax and Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Brittany Knick Ragon, Justin M. Watts, John Bomalaski, Amanda Johnston, Mirla Langlois, Nicole DeFord Chang, Gautam Borthakur
Journal: Blood
Blood (2024) 144 (Supplement 1): 6000.
https://doi.org/10.1182/blood-2024-201074
Published: 2024
Journal Articles

A Phase 1A/B Combination Study of Pegargiminase (ADI-PEG 20), Venetoclax and Azacitidine in Patients with Acute Myeloid Leukemia

Brittany Knick Ragon, John Bomalaski, Amanda Johnston, Mirla Langlois, Nicole DeFord Chang, Gautam Borthakur
Journal: Blood
Blood (2023) 142 (Supplement 1): 1554.
https://doi.org/10.1182/blood-2023-174954
Published: 2023
Journal Articles

High Deliverability of a Midostaurin Triplet Regimen Incorporating Venetoclax and Low Dose Cytarabine in Non-Adverse Cytogenetic Risk Acute Myeloid Leukaemia: A Sub-Analysis of the Australasian Leukaemia Lymphoma Group (ALLG) Intervene Study

Chong Chyn Chua, Natasha S Anstee, Anoop Kumar Enjeti, Devendra Hiwase, Paula Marlton, Ashish Bajel, Shuh Ying Tan, Edward S. Morris, Chun-Kei-Kris Ma, Carolyn Grove, Julian Cooney, Ashanka Beligaswatte, Rachel M Koldej, Stephen B Ting, Travis Perera, Amanda Johnston, John Reynolds, David Ritchie, Andrew H Wei
Journal: Blood
Blood (2022) 140 (Supplement 1): 3362–3364.
https://doi.org/10.1182/blood-2022-163084
Published: 2022
Journal Articles

Long Term Follow-up of International Randomised Phase 3 Study of Rituximab Versus a Watch and Wait Approach for Patients with Asymptomatic, Low Tumour Burden Follicular Lymphoma Shows Rituximab Is Highly Effective at Delaying Time to New Treatment without Detrimental Impact Following Next Line of Therapy

Michael Northend, William Wilson, Laura Clifton-Hadley, Zaynab Rana, Tanya-Louise Martin, Moya Young, Fiona Miall, David Cunningham, Jan Walewski, Burhan Ferhanoglu, Amanda Johnston, John F. Seymour, David C. Linch, Kirit M. Ardeshna
Journal: Blood
Blood (2022) 140 (Supplement 1): 1456–1458.
https://doi.org/10.1182/blood-2022-156790
Published: 2022
Journal Articles

Efficacy of Ibrutinib, Rituximab and Mini-CHOP in Very Elderly Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma: Primary Analysis of the Australasian Leukaemia & Lymphoma Group NHL29 Study

Emma Verner, Amanda Johnston, Nalini Pati, Eliza Hawkes, Hui-Peng Lee, Tara Cochrane, Chan-Yoon Cheah, Robin J Filshie, Duncan Purtill, Hanlon Sia, Anoop Kumar Enjeti, Christina Brown, Nicholas E. Murphy, Jennifer Curnow, Kenneth Lee, Mannu Walia, Belinda Butcher, Judith Trotman
Journal: Blood
Blood (2021) 138 (Supplement 1): 304.
https://doi.org/10.1182/blood-2021-149019
Published: 2021
Journal Articles

An Australasian Leukemia Lymphoma Group (ALLG) Phase 2 Study to Investigate Novel Triplets to Extend Remission with Venetoclax in Elderly (INTERVENE) Acute Myeloid Leukemia

Chong Chyn Chua, John Reynolds, Anoop Kumar Enjeti, Devendra Hiwase, Paula Marlton, Ashish Bajel, Shuh Ying Tan, Edward S. Morris, Chun-Kei-Kris Ma, Carolyn Grove, Julian Cooney, Ashanka Beligaswatte, Natasha Anstee, Stephen B Ting, Travis Perera, Amanda Johnston, David Ritchie, Andrew H. Wei
Journal: Blood
Blood (2021) 138 (Supplement 1): 368.
https://doi.org/10.1182/blood-2021-149488
Published: 2021
Journal Articles

Combination of Idasanutlin, Venetoclax and Obinutuzumab in Patients with Relapsed or Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Results from a Phase I/II Study

Manali Kamdar, MD, Bradley Augustson, MBBS FRACP FRCPA, Young Rok Do, PhDMD, James Edwards, Mark Hertzberg, MBBS PhDFRACP FRCPA, Amanda Johnston, FRACP,FRCPA,MBBS,BMBS,MD, Jin Seok Kim, MD PhD, Frank P. Kroschinsky, MDMBA, Sonali M. Smith, MD, Don A. Stevens, MD, Annabelle Monnet, Ye Zhao, Yann Nouet, PhD MSc, Viktoriya Marinova
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-136221
Published: 2020
Journal Articles

Response Rates and Quality of Life Outcomes in Australasian Leukaemia & Lymphoma Group NHL29: A Phase II Study of Ibrutinib, Rituximab and Mini-CHOP in Very Elderly Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma

Emma Verner, MBBS, BMedSci,FRCPA, FRACP, Amanda Johnston, FRACP,FRCPA,MBBS,BMBS,MD, Nalini Pati, MBBS,FRACP,FRCPA, DCH, MD DNB, Eliza A Hawkes, Hui-Peng Lee, MBChB, FRACP, FRCPA, BHB, Tara Cochrane, MBBS,FRCPA,FRACP, Chan Y. Cheah, Duncan Purtill, MBBS,FRCPA,FRACP, Anoop K Enjeti, MBBS,FRCPA, FRACP,PhDMD,MRCP, Christina Brown, PhDFRACP,FRCPA,MBBS, Nicholas E. Murphy, FRCPA,MBBS,FRACP, Jennifer Curnow, MBBS, FRACP, FRCPA, PhD, Julia Carlson, Belinda Butcher, BSci, MBiostat, PhD, Judith Trotman, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 4094.
https://doi.org/10.1182/blood-2019-124621
Published: 2019
Journal Articles

Treatment of Steroid-Refractory Acute Graft Versus Host Disease with Low Dose Combination Monoclonal Antibody Therapy: A Pilot Study.

John J. Moore, MBBS, FRACP, FRCPA, Amanda Johnston, MBBS, BSc, Ma D.F. David, MBBS, PhD, FRACP, Milliken Sam, MBBS, FRCPA, FRACP, Fay Keith, MBBS, FRCPA, FRACP, Dodds Tony, MBBS, FRCPA, FRACP
Journal: Blood
Blood (2004) 104 (11): 1255.
https://doi.org/10.1182/blood.V104.11.1255.1255
Published: 2004